MINNEAPOLIS — Provation has appointed Dr. Lukasz Kowalczyk as Executive Medical Director, marking a major step in the company’s mission to lead provider-centric innovation in healthcare technology. A nationally recognized gastroenterologist and health tech innovator, Dr. Kowalczyk brings deep clinical expertise and a forward-looking approach to artificial intelligence that aligns with Provation’s goal of advancing healthcare quality and productivity worldwide.
“We believe that true innovation begins with deep clinical insight and a passion for improving patient outcomes,” said Ankush Kaul, president of Provation. “Dr. Kowalczyk embodies this belief, and we are thrilled to welcome him to our team.”
Dr. Kowalczyk joins Provation with an extensive background in both clinical practice and AI-driven health technology. A graduate of the Mayo Clinic AI Accelerator and a member of the HIMSS AI Advisory Group, he is widely respected for his leadership in responsible and scalable AI adoption. His proprietary Clinical Enterprise Value Stack (CEVS) framework will help guide Provation’s strategy to deliver measurable clinical and financial returns for healthcare organizations.
With his ongoing experience as a practicing gastroenterologist and history of building successful health tech ventures, Dr. Kowalczyk brings a provider’s perspective to innovation. His leadership will ensure that Provation’s technologies remain closely aligned with real-world clinical workflows, empowering physicians, hospitals, and health systems to adopt smarter, more efficient digital solutions.
“Provation’s vision centers on designing with empathy, precision, and a deep understanding of provider needs,” said Dr. Kowalczyk. “I’m excited to help shape the future of healthcare technology in a way that truly reflects the realities of clinical practice.”
In his new role, Dr. Kowalczyk will represent Provation at key industry conferences, medical societies, and advisory boards, contributing to national and global discussions on clinical quality, interoperability, and the future of procedural care. His insights will play a central role in shaping Provation’s product strategy to align with emerging industry standards and evolving customer needs.
Backed by Fortive and supported by more than 30 years of enterprise experience, Provation is positioned to scale its innovation across the healthcare continuum. Dr. Kowalczyk’s leadership will help translate the company’s technology capabilities into solutions that deliver meaningful impact at the point of care.
